Literature DB >> 18094940

Early OCT changes of neuroretinal foveal thickness after first versus repeated PDT in AMD.

Gennady Landa1, Amir Bukelman, Haya Katz, Ayala Pollack.   

Abstract

PURPOSE: To compare early optical coherence tomography (OCT) changes in neuroretinal foveal thickness (NFT) after first versus repeated photodynamic treatment (PDT) in eyes with choroidal neovascularization (CNV) due to age-related macular degeneration (AMD).
METHODS: This is a prospective comparative case series study. Consecutive AMD patients, treated with PDT due to subfoveal CNV, were enrolled. The eyes were divided into two groups: group A included eyes that had received the first initial treatment, and group B included eyes that had received repeated treatment. All eyes underwent serial examinations with OCT: prior to PDT, 1 h, and 3 months after the PDT. The primary outcome measure was early OCT change in NFT after PDT.
RESULTS: Thirty-three eyes of 33 patients were included in this study; 16 in group A and 17 in group B. Optical coherence tomography showed a significant increase in NFT 1 h after PDT, as compared to pre-treatment status, in group A eyes (P = 0.008) but not in group B eyes (P = 0.731). Subretinal fluid was increased in both groups (93.8% and 88.2%, respectively), whereas intraretinal fluid was remarkably more increased in group A eyes (88%) than in group B eyes (59%).
CONCLUSION: Early change in NFT, demonstrated on OCT, indicates that PDT causes different retinal response in primary versus repeated treatment of PDT for CNV due to AMD.

Entities:  

Mesh:

Year:  2007        PMID: 18094940     DOI: 10.1007/s10792-007-9176-0

Source DB:  PubMed          Journal:  Int Ophthalmol        ISSN: 0165-5701            Impact factor:   2.031


  18 in total

1.  Optical coherence tomography findings following photodynamic therapy of choroidal neovascularization.

Authors:  Adam H Rogers; Adam Martidis; Paul B Greenberg; Carmen A Puliafito
Journal:  Am J Ophthalmol       Date:  2002-10       Impact factor: 5.258

2.  Electron microscopic study of monkey retina after photodynamic treatment.

Authors:  Yoshitaka Ohnishi; Takeshi Yoshitomi; Toshinori Murata; Taiji Sakamoto; Tatsuro Ishibashi
Journal:  Med Electron Microsc       Date:  2002-03

3.  Ocular changes after photodynamic therapy.

Authors:  Radouil Tzekov; Ton Lin; Kai-Ming Zhang; Brittany Jackson; Adelekan Oyejide; Werhner Orilla; Amol D Kulkarni; Baruch D Kuppermann; Larry Wheeler; James Burke
Journal:  Invest Ophthalmol Vis Sci       Date:  2006-01       Impact factor: 4.799

4.  Optical coherence tomography in photodynamic therapy for subfoveal choroidal neovascularisation secondary to age related macular degeneration: a cross sectional study.

Authors:  J Sahni; P Stanga; D Wong; S Harding
Journal:  Br J Ophthalmol       Date:  2005-03       Impact factor: 4.638

5.  Retinal thickness study with optical coherence tomography in patients with diabetes.

Authors:  Hortensia Sánchez-Tocino; Aurora Alvarez-Vidal; Miguel J Maldonado; Javier Moreno-Montañés; Alfredo García-Layana
Journal:  Invest Ophthalmol Vis Sci       Date:  2002-05       Impact factor: 4.799

6.  Effects of photodynamic therapy using verteporfin on experimental choroidal neovascularization and normal retina and choroid up to 7 weeks after treatment.

Authors:  D Husain; M Kramer; A G Kenny; N Michaud; T J Flotte; E S Gragoudas; J W Miller
Journal:  Invest Ophthalmol Vis Sci       Date:  1999-09       Impact factor: 4.799

7.  Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: two-year results of a randomized clinical trial including lesions with occult with no classic choroidal neovascularization--verteporfin in photodynamic therapy report 2.

Authors: 
Journal:  Am J Ophthalmol       Date:  2001-05       Impact factor: 5.258

8.  Sequence of early vascular events after photodynamic therapy.

Authors:  Stephan Michels; Ursula Schmidt-Erfurth
Journal:  Invest Ophthalmol Vis Sci       Date:  2003-05       Impact factor: 4.799

9.  Effect of lesion size, visual acuity, and lesion composition on visual acuity change with and without verteporfin therapy for choroidal neovascularization secondary to age-related macular degeneration: TAP and VIP report no. 1.

Authors:  Keven J Blinder; Shannon Bradley; Neil M Bressler; Susan B Bressler; Guy Donati; Yong Hao; Colin Ma; Ugo Menchini; Joan Miller; Michael J Potter; Constantin Pournaras; Al Reaves; Philip J Rosenfeld; H Andrew Strong; Michael Stur; Xiang Yao Su; Gianni Virgili
Journal:  Am J Ophthalmol       Date:  2003-09       Impact factor: 5.258

10.  Dose-related structural effects of photodynamic therapy on choroidal and retinal structures of human eyes.

Authors:  Ursula Schlötzer-Schrehardt; Arne Viestenz; Gottfried O H Naumann; Horst Laqua; S Michels; Ursula Schmidt-Erfurth
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2002-08-27       Impact factor: 3.117

View more
  1 in total

1.  Recovery of photoreceptor outer segments after anti-VEGF therapy for age-related macular degeneration.

Authors:  Akio Oishi; Masataka Shimozono; Michiko Mandai; Masayuki Hata; Akihiro Nishida; Yasuo Kurimoto
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2012-05-12       Impact factor: 3.117

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.